Manual Of Clinical Oncology

[Ottavia Delamar]

TheManual of Clinical Oncology, Ninth Edition, published with the International Union Against Cancer (UICC), provides a concise, accessible and feasible reference covering state of art multidisciplinary clinical oncology in order to meet the needs of clinicians caring for cancer patients throughout the world.

Edited by world-renowned practising oncologists and written by key opinion leaders, this book contains authoritative and up-to-date information on cancer detection, diagnosis and treatment alongside topics such as survivorship, special populations and palliative care.

Remodelled and revised for the ninth edition to provide practical information to oncology workers, the UICC Manual of Clinical Oncology is structured in two parts. Part 1 covers general principles of cancer diagnosis and management with additional attention to special settings in oncology, including supportive care and survivorship, and Part 2 covers site-specific multidisciplinary cancer management. The edition includes up-to-date summaries of all treatment modalities (medical, surgical and radiation) for all tumour sites. It also contains the latest TNM classifications outlined in the TNM Classification of Malignant Tumours.

The ninth edition includes:

Practical presentation with bullet points, tables, and flow charts intended to facilitate quick reference for day-to-day clinical practice in busy oncology environments,

Representation of multidisciplinary care for site specific management,

Evidence-based approaches to management, including specific treatment recommendations and investigations guided by clinical practice guidelines,

State of art evidence-based recommendations that take into consideration the lack of availability of certain medications or resources, as well as practice variations, in different and remote regions of the world, and

Contemporary topics on cancer treatment, such as cancer informatics, evidence levels, principles of prognostication, survivorship and cancer in pregnancy.

Oncologists, oncologists-in-training, nurses working with cancer patients and other health professionals responsible for treating and caring for those with cancers will find the UICC Manual of Clinical Oncology an indispensable and comprehensive resource.

James Brierley is a Professor in the Department of Radiation Oncology at the University of Toronto, Princess Margaret Cancer Centre. He obtained his medical degree from Westminster Medical School, University of London. He initially did postgraduate training in Internal Medicine before transferring to Clinical Oncology. He is interested in the management of gastrointestinal malignancy and thyroid malignancy and cancer staging and surveillance. He has written extensively on thyroid cancer, the role of radiation in gastrointestinal malignancy and cancer staging and surveillance and is actively involved in research into the role of radiation in the management of gastrointestinal and endocrine malignancies and ensuring staging data is collected and used on a population basis. He is the previous head of the Gastrointestinal Site Group at the Princess Margaret Cancer Centre and is currently the Canadian Partnership Against; Cancer Expert Lead, Staging and Surveillance. He is a Member of the AJCC Executive and Chair of the AJCC Education and Promotions Working Group, Co-Chair of the UICC TNM Prognostic Factors Core Group and Co-Editor of the UICC 8th edition TNM Classification of Malignant Tumours.

Martin Fey is a Professor and Head of Department of Medical Oncology at the University of Berne, Switzerland. He is also Head of the Department of Oncology, Laboratory medicine and Hospital Pharmacy at the Inselspital Bern. He received his medical degree from the Berne University Medical School. He was the recipient of Robert-Wenner Award of the Swiss Cancer League and Ellermann Award of the Swiss Society of Haematology. He has more than 250 peer-reviewed publications to his credit, mainly in clinical and experimental haematological oncology. He leads clinical trials in leukaemia, lymphoma, breast cancer and other types of tumours. He was the Chairman of the Leukaemia Group of the Swiss Group for Clinical Cancer Research (SAKK) from 1990-1995 and a Principal Investigator of the SAKK and the International Breast Cancer Study Group (IBCSG) from 1993-2002. His interests include leukaemia, lymphoma, breast cancer, and the design of clinical trials. He is a member of the Cantonal Ethics Committee for Clinical Trials of the Canton of Bern, Switzerland.

Raphael Pollock, M.D., Ph.D. was born in Chicago, Illinois and graduated from Oberlin College, Oberlin, Ohio in 1972. This was followed by medical school at the St. Louis University School of Medicine Chicago, IL residencies in General Surgery at the University of Chicago and Rush Medical College, a fellowship in Surgical Oncology at The University of Texas M. D. Anderson Cancer Center, and a Ph.D. in Tumor Immunology from the Graduate School of the Biological Sciences at the University of Texas-Houston Health Sciences Center. Dr. Pollock joined the Department of Surgical Oncology at The University of Texas M. D. Anderson Cancer Center as a faculty member in 1984. Dr. Pollock became Chairman of the Department of Surgical Oncology in 1993 and became Head of the Division of Surgery at The University of Texas M. D. Anderson Cancer Center in 1997. In 2006-07 Dr. Pollock served as President of the Society of Surgical Oncology; from 1999-2011 he served as Editor-in-Chief of Cancer. In 2013 Dr. Pollock left MD Anderson to become Director and Professor, Division of Surgical Oncology and Chief of Surgical Services at The James Comprehensive Cancer Center at The Ohio State University Medical Center, Columbus, Ohio. Dr. Pollock serves as Director of the Sarcoma Research Laboratory at The Ohio State University Medical Center and is the Principal Investigator on behalf of the US NIH/NCI SARC Sarcoma SPORE grant program. Dr. Pollock is a member of the US NIH/NCI Board of Scientific Counselors.

Jan B. Vermorken was born in 1944, graduated in 1970 from the University of Amsterdam, the Netherlands and became a board-certified specialist in internal medicine in 1975. Since that time he has worked in the field of Medical Oncology and was officially registered as a Medical Oncologist in the Netherlands in 1992. He received his PhD in Medical Sciences in 1986 from the Vrije Universiteit in Amsterdam. From May 1997 until October 1, 2009, he was Professor of Oncology at the University of Antwerp (UA), and head of the Department of Medical Oncology at the University Hospital Antwerp (UZA), in Edegem, Belgium. After his retirement he remains connected to both University (emeritus Professor) and University Hospital.

Manual of Clinical Oncology is a concise pocket manual that incorporates basic science, clinical findings, and available technology into the diagnosis and management of cancer. It focuses on information useful for participating in rounds and for making diagnostic and therapeutic decisions at the bedside of cancer patients. The seventh edition is a practical, accessible, comprehensive guide to the management of patients with cancer.

Produced under the direction of ESMO, the Handbooks series is intended to appeal to all healthcare professionals working in oncology. The handbooks are comprehensive guides which provide concise, first-hand advice in a practical, easy-to-read format.

This handbook describes the major types of malignancy which might occur during this transitional phase of life. It provides diagnostic and therapeutic guidance and also gives an idea of life after cancer. ESMO and SIOP Europe share the same goal: that no young person should have to die of cancer.

This handbook brings together specialists in the field of precision medicine, who have shared their knowledge and given their insights on this broad topic, providing you with a solid base to understand this field from basic science to clinical application.

This handbook enables all of us to read between the lines of a scientific publication, to better estimate the true benefit of a new oncological intervention and to better understand other cancer-related research.

The aim of the present edition of the ESMO Handbook of Oncological Emergencies is to approach the new advances and developments in the field of oncological emergency treatments, for the benefit of oncology specialists, but also for those who are just starting out in this profession.

This Handbook is a rare attempt to make an appraisal of where we are in the field of cancer diagnosis and treatment evaluation, by focusing on some key issues of the clinical method of medical oncologists.

The treatment of any patient, in particular seniors, requires a careful evaluation of the person who is in need of such treatment. This handbook focuses on the delicate decision-making process, which should lead to the best therapy, adapted not only to the disease but also to the person who suffers from it

In this ESMO Handbook the editors cover topics including the emerging processes of evading tumour destruction and tumour inflammation, new challenges posed by tumour heterogeneity, and new study designs and technologies.

This is a user-friendly handbook, designed for young medical oncologists, where they can access the essential information they need for providing the treatment which could have the highest chance of being effective and tolerable.

ASCOconnection.org features blogs from members, the online version of the membership magazine, a discussion area, working groups, and links to the Membership Directory, Career Center, and Volunteer Portal.

ASCO Daily News is the official conference reporter for ASCO meetings and symposia, providing high-quality, unbiased research summaries and oncology news to members and oncology health care providers.

A cutting-edge health information technology platform, CancerLinQ enables practitioners to learn from individual patients. By assembling vast amounts of usable, searchable, real-world data, CancerLinQ seeks to improve the quality and value of cancer care.

3a8082e126